SON.HO.UN.ADR 1/5 SF -05 - Asset Resilience Ratio
SON.HO.UN.ADR 1/5 SF -05 (PHBA) has an Asset Resilience Ratio of 0.19% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how SON.HO.UN.ADR 1/5 SF -05's Asset Resilience Ratio has changed over time. See SON.HO.UN.ADR 1/5 SF -05 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down SON.HO.UN.ADR 1/5 SF -05's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of SON.HO.UN.ADR 1/5 SF -05.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €10.50 Million | 0.19% |
| Total Liquid Assets | €10.50 Million | 0.19% |
Asset Resilience Insights
- Limited Liquidity: SON.HO.UN.ADR 1/5 SF -05 maintains only 0.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SON.HO.UN.ADR 1/5 SF -05 Industry Peers by Asset Resilience Ratio
Compare SON.HO.UN.ADR 1/5 SF -05's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Scibase AB
ST:SCIB |
Medical Devices | 43.33% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 33.68% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Vieworks Co. Ltd
KQ:100120 |
Medical Devices | 7.81% |
Annual Asset Resilience Ratio for SON.HO.UN.ADR 1/5 SF -05 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for SON.HO.UN.ADR 1/5 SF -05.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.92 Billion ≈ $6.93 Billion |
0.00pp |
| 2024-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.79 Billion ≈ $6.77 Billion |
0.00pp |
| 2023-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.55 Billion ≈ $6.49 Billion |
+0.00pp |
| 2022-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.59 Billion ≈ $6.53 Billion |
-- |
About SON.HO.UN.ADR 1/5 SF -05
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hea… Read more